In the current study, we sought to investigate the levels of ATG5, UBQLN2, ULK1, and LC3 proteins in different brain regions (the temporal, frontal, and occipital cortex) and in the plasma of patients affected by AD, DLB, and FTD, to identify common mechanisms. This evidence concerns the gene ATG5 and Alzheimer disease.